Developmental immunology and vaccines: Immune responses to vaccines in premature infants

Expert Review of Vaccines

Volumn 3, Issue 4, 2004, Pages 343-347

  Roberton, D M ^a   Marshall, H ^a   Dinan, L ^b   Boros, C ^c   Gold, M ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b ROYAL ADELAIDE HOSPITAL   (Australia)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACELLULAR VACCINE; ANTIBODY; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEMAGGLUTININ; HEPATITIS B VACCINE; INACTIVATED VACCINE; MENINGOCOCCUS VACCINE; ORAL POLIOMYELITIS VACCINE; PERTUSSIS TOXIN; PNEUMOCOCCUS VACCINE; STEROID; VACCINE;

ANTIBODY AFFINITY; ANTIGEN BINDING; APNEA; DEVELOPMENTAL BIOLOGY; DRUG EFFICACY; DRUG SAFETY; HIGH RISK POPULATION; HUMAN; IMMATURITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; IMMUNOLOGY; NEWBORN; NEWBORN INFECTION; PREMATURITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TREATMENT FAILURE; VACCINATION;

HAEMOPHILUS VACCINES; HEPATITIS B VACCINES; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MENINGOCOCCAL VACCINES; PERTUSSIS VACCINE; POLIOVIRUS VACCINES; POLYSACCHARIDES, BACTERIAL; VACCINES;

EID: 4043062220     PISSN: 14760584     EISSN: None     Source Type: Journal    
DOI: 10.1586/14760584.3.4.343     Document Type: Review

References (20)

1. Global Alliance For Vaccines and Immunization (GAVI). Fact sheet number 169, March (2001).
2. Heath PT, Booy R, Griffiths H et al. Clinical and immunological risk factors associated with Haemophilus influenzae type b conjugate vaccine failure in childhood. Clin. Infect. Dis. 31, 973-980 (2000).
3. Boros CA, Mcphee A, Gold MS, Hanlon M, Roberton DM. Antibody responses to immunization in premature and term infants. J. Pediatr. Child Health 37, A3-A4 (2001).
4. Robinson MJ, Campbell F, Powell P, Sims D, Thorton C. Antibody response to accelerated Hib immunization in preterm infants receiving dexamethasone for chronic lung disease. Arch. Dis. Child Fetal Neonatal Ed. 80, F69-F71 (1999).
5. Washburn LK, O'Shea TM, Gillis DC, Block SM, Abrahamson JS. Response to Haemophilus influenzae type b conjugate vaccine in chronically ill premature infants. J. Pediatr. 123(5), 791-794 (1993).
6. Greenberg DP, Vadheim CM, Patridge S et al. Immunogenicity of Haemophilus influenzae type b tetanus toxoid conjugate vaccine in young infants. J. Infect. Dis. 170, 76-81 (1994).
7. Munoz A, Salvador A, Brodsky NL, Arbeter AM, Porat R. Antibody response of low birth-weight infants to Haemophilus influenzae type b polyribosylribitol phosphate-outer membrane protein conjugate vaccine. Pediatrics 96(2), 216-219 (1995).
8. Dinan L. Antibody responses after Hib immunization in premature and term infants. MPH Thesis, University of Adelaide, Australia (1998).
9. Slack M, Schapira D, Thwaites RJ et al. Immune response of premature infants to meningococcal serogroup C and combined diphtheria-tetanus toxoids-acellular pertussis-Haemophilus influenzae Type b conjugate vaccines. J. Infect. Dis. 184, 1617-1620 (2001).
10. Boros C. Factors affecting the immunogenicity and protective efficacy of routine childhood immunization. PhD Thesis, University of Adelaide, Australia (2002).
11. Schloesser R, Fischer D, Otto W, Rettwitz-Volk, Herden P, Zielen S. Safety and immunogenicity of an acellular pertussis vaccine in premature infants. Pediatrics 103, 5(E60) (1999).
12. Linder N, Handsher R, German B et al. Controlled trial of immune response of preterm infants to recombinant hepatitis B and inactivated poliovirus vaccines administered simultaneously shortly after birth. Arch. Dis. Child Fetal Neonatal Ed. 83, F24-F27 (2000).
13. Kirmani K, Lofthus G, Pichichero M, Voloshen T, D'Angio C. 7-year follow-up of vaccine response in extremely premature infants. Pediatrics 109, 498-504 (2002).
14. Linder N, Vishne TH, Levin E et al. Hepatitis B vaccination: long-term follow-up of the immune response of preterm infants and comparison of two vaccination protocols. Infection 30, 136-139 (2002).
15. Kim SC, Chung EK, Hodinka RL et al. Immunogenicity of hepatitis B vaccine in preterm infants. Pediatrics 99, 534-536 (1997).
16. West DJ, Margolis HS. Prevention of hepatitis B virus infection in the United States: a pediatric perspective. Pediatr. Infect. Dis. J. 11, 866-874 (1992).
17. Shinefield HR, Black S. Efficacy of peumococcal conjugate vaccines in large-scale field trials. Pediatr. Infect. Dis. J. 19, 394-397 (2000).
18. Esposito S, Faldella G, Giammanco A et al. Long-term pertussis-specific immune responses to a combined diphtheria, tetanus, tricomponent acellular pertussis and hepatitis B vaccine in pre-term infants. Vaccine 20, 2928-2932 (2002).
19. Saari T. Immunization of preterm and low birth-weight Infants. Pediatrics 112, 193-198 (2003).
20. The Australian Immunization Handbook. 8th edition NHMRC (2003).